Mitsuko L Yamamoto

US Patent:

20230035667, Feb 2, 2023

Filed:

Jan 15, 2021

Appl. No.:

17/758748

Inventors:

- Brisbane CA, US
Shoko Kawana - San Mateo CA, US
Mitsuko Lynn Yamamoto - Brisbane CA, US

International Classification:

A61K 35/741
G01N 33/569
A61P 3/10
C12N 7/00

Abstract:

Methods and compositions are provided herein for treating type 2 diabetes in a subject, using one or more bacterial strains such as sp. HGB5, type strain (IPP 1246), DSM 22519, T9-40 A, B2-52, CB35, A2-194, sp. 5.1.39BFAA, and CARI.

US Patent:

20200376044, Dec 3, 2020

Filed:

Aug 3, 2018

Appl. No.:

16/636615

Inventors:

- South San Francisco CA, US
Mitsuko Lynn Yamamoto - South San Francisco CA, US
Todd Zachary DeSantis - South San Francisco CA, US
Karim Dabbagh - South San Francisco CA, US

International Classification:

A61K 35/741
A61P 3/10
A61P 3/04
A61P 1/00

Abstract:

The disclosure relates to live biotherapeutic products, probiotics, pharmaceutical compositions comprising said probiotics, and methods of using them to treat various human diseases. In some aspects, the disclosure provides such compositions comprising strains of the bacteria and and their uses in treating metabolic-related diseases or disorders.

US Patent:

20200237829, Jul 30, 2020

Filed:

Aug 6, 2018

Appl. No.:

16/637068

Inventors:

- South San Francisco CA, US
Bernat Baeza Raja - South San Francisco CA, US
Shoko Kawana - South San Francisco CA, US
Mitsuko Lynn Yamamoto - South San Francisco CA, US
Karim Dabbagh - South San Francisco CA, US
Todd Zachary DeSantis - South San Francisco CA, US

International Classification:

A61K 35/74
A23L 33/135
A61P 3/10

Abstract:

The disclosure relates to live biotherapeutic products, probiotics, pharmaceutical compositions comprising said probiotics, and methods of using them to treat various human diseases. In some aspects, the disclosure provides such compositions comprising strains of the bacterium and their uses in treating metabolic-related diseases or disorder.

US Patent:

20200237830, Jul 30, 2020

Filed:

Aug 6, 2018

Appl. No.:

16/651041

Inventors:

- South San Francisco CA, US
Bernat Baeza Raja - South San Francisco CA, US
Shoko Kawana - South San Francisco CA, US
Mitsuko Lynn Yamamoto - South San Francisco CA, US
Karim Dabbagh - South San Francisco CA, US
Todd Zachary DeSantis - South San Francisco CA, US

International Classification:

A61K 35/74
A23L 33/135
A61P 3/10

Abstract:

The disclosure relates to live biotherapeutic products, probiotics, pharmaceutical compositions comprising said probiotics, and methods of using them to treat various human diseases. In some aspects, the disclosure provides such compositions comprising strains of the bacterium and their uses in treating metabolic-related diseases or disorder.